The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis

Abstract : The nuclear bile acid receptor FXR is a PKA-and FOXA2-sensitive activator of fasting hepatic gluconeogenesis Graphical abstract Authors Gluconeogenesis control by FXR Glucagon cAMP PKA CREB SHP BAs FXR::FOXA2 FXR S325,357P Gluconeogenesis Glucose Hepatocyte Highlights FXR synergizes with the glucagon signaling pathway to regulate hepatic gluconeogenesis in vivo and in vitro. FXR positively regulates gluconeogenic genes through PKA-catalyzed phosphorylation. The glucagon-regulated transcription factor FOXA2 negatively regulates FXR's ability to activate the expression of the SHP. Lay summary Activation of the nuclear bile acid receptor FXR regulates gene expression networks , controlling lipid, cholesterol and glucose metabolism, which are mostly effective after eating. Whether FXR exerts critical functions during fasting is unknown. The results of this study show that FXR transcriptional activity is regulated by the glucagon/protein kinase A and the FOXA2 signaling pathways, which act on FXR through phosphorylation and protein-protein interactions, respectively, to increase hepatic glucose synthesis.
Complete list of metadatas

Cited literature [57 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02108132
Contributor : Marie-Hélène Derudas <>
Submitted on : Wednesday, April 24, 2019 - 8:58:45 AM
Last modification on : Monday, October 21, 2019 - 4:36:21 PM

File

Ploton J Hepatol.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Maheul Ploton, Claire Mazuy, Celine Gheeraert, Vanessa Dubois, Alexandre Berthier, et al.. The nuclear bile acid receptor FXR is a PKA- and FOXA2-sensitive activator of fasting hepatic gluconeogenesis. Journal of Hepatology, Elsevier, 2018, 69 (5), pp.1099-1109. ⟨10.1016/j.jhep.2018.06.022⟩. ⟨inserm-02108132⟩

Share

Metrics

Record views

55

Files downloads

114